China Justice Observer

中司观察

EnglishArabicChinese (Simplified)DutchFrenchGermanHindiItalianJapaneseKoreanPortugueseRussianSpanishSwedishHebrewIndonesianVietnameseThaiTurkishMalay

China Issues Rules on Medical Ethics Involving Human Beings

Mon, 10 Jul 2023
Categories: China Legal Trends

It refers to the “Measures for Ethical Review of Life Science and Medical Research Involving Human Beings” (hereinafter the “Measures”, 涉及人的生命科学和医学研究伦理审查办法),  published on 18 Feb. 2023.

The Measures is released by China’s National Health Commission, Ministry of Education, Ministry of Science and Technology, and National Administration of Traditional Chinese Medicine.

The Measures aims to strike a balance between safeguarding human dignity, protecting the rights of researchers and promoting the development of life science and medical research.

Life science and medical research involving human beings refers to the following research activities carried out with biological samples and information data with human beings as subjects or users:

  • Activities of research on human reproduction, growth, development and senescence;
  • Activities of research on human physiological and psychological behaviors, pathological phenomena, etiology and pathogenesis of diseases, as well as prevention, diagnosis, treatment and rehabilitation of diseases;
  • Activities of experimental research on human beings; and
  • Activities of collecting, recording, using, reporting or storing biological samples, information data (including health records, behaviors, etc.) on life science and medical problems involving human beings.

Institutions conducting life science and medical research involving human beings shall establish ethical review committees to conduct ethical reviews of the aforementioned research activities.

 

Photo by Yilin Liu on Unsplash

Contributors: CJO Staff Contributors Team

Save as PDF

You might also like

PRC Double Interest neither Double nor Penal, Australian Courts Clear Its Name When Enforcing Chinese Judgments

Recent Australian case law clarifies that the “double interest” mechanism in the People’s Republic of China (PRC) monetary judgments functions as a compensatory post-judgment interest framework rather than an unenforceable penalty. This consolidates Australia’s position as a highly attractive and creditor-friendly forum for enforcing Chinese judgments. See Zhengzhou Lvdu Real Estate Group Co v Shu [2024] NSWSC 58 (6 February 2024), Fu v Pang [2025] VSC 597 (16 September 2025)

IOMed Settles First Case, Resolving China-Singapore Maritime Dispute

The newly established International Organization for Mediation (IOMed) has successfully resolved its inaugural case—a maritime charter dispute between Chinese and Singaporean parties—marking a major milestone for the world’s first government-backed global mediation body.

China Overhauls Arbitration Law for Global Alignment

Having entered into force on March 1, 2026, China’s first comprehensive revision of its 1995 Arbitration Law has introduced ad hoc arbitration, strengthened interim relief, and aligned the legal framework more closely with international standards.